Phase 2 Study in Patients With MiT Tumors

Conditions

• Renal Cell Carcinoma (RCC)
• Alveolar Soft Part Sarcoma (ASPS)
• Clear Cell Sarcoma (CCS)

Interventions

• DRUG: ARQ 197

Sponsor

ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)